All Stories
Featured Stories
Beyond the Clinical: How Social Workers Drive Kidney Transplant Success
DaVita Honors Extraordinary Nurses with the 2026 DAISY Awards
Evaluating Innovations in Middle Molecule Clearance
This content is available for reuse with permission. If you are interested in reusing this content, please email newsroom@davita.com.
-
Beyond the Clinical: How Social Workers Drive Kidney Transplant Success
While kidney transplant is the optimal treatment path for end stage kidney disease (ESKD), complex logistical, financial and educational barriers can often stand in the way for many patients interested in pursuing it. The process can require rigorous medical, financial and emotional preparation. Clinical social workers help with this. In addition to guiding patients to […]
-
DaVita Honors Extraordinary Nurses with the 2026 DAISY Awards
Nurses are the heart of healthcare, combining clinical expertise with a deep sense of empathy and dedication. This year, DaVita announces 57 exceptional nephrology nurses have been honored with the 2026 DAISY Award® for Extraordinary Nurses, celebrating the profound impact they make on the lives of our patients and their families. The DAISY Award is […]
-
Evaluating Innovations in Middle Molecule Clearance
“The secret of the care of the patient is in caring for the patient.”¹ None of us would ever choose to have kidney failure. And that is exactly why innovations that help patients feel better and live healthier are critical to our work serving the kidney community. Middle molecule clearance is emerging as a meaningful […]
-
Heart, Kidney & Metabolic Care: A Strategic Imperative for Health Systems
For U.S. healthcare systems, clinical and financial stability can be achieved when we look beyond treatment options for individual disease states and instead take a more holistic approach that also addresses the pathological mechanisms that extend across multiple disease states. The American Heart Association definition of the cardiovascular-kidney-metabolic syndrome (CKM syndrome), a systemic overlap of […]
-
SGLT2 Inhibitors Could Play Role in Slowing Kidney Disease Progression
For years, kidney care has primarily focused on managing kidney failure. Now, new data is empowering a crucial clinical focus: preserving kidney function before kidney disease advances. A recent study published in JAMA Internal Medicine provides a compelling signal for care providers: When it comes to slowing chronic kidney disease (CKD) progression for people with […]